UBIOME, INC.
SAN FRANCISCO, CA

We are pioneering a new era of microbiome-based precision medicine. uBiome is the leading microbial genomics company. CNN’s close look at 30 innovative companies that are changing the world; uBiome selected in the Futurist Category uBiome Ranked #6 for Most Innovative Companies in the Healthcare Category Business Insider: 30 Under 30 uBiome was founded in 2012 by Stanford-, Oxford-, and UCSF-educated researchers. We are funded by Y Combinator, Andreessen Horowitz, and other leading investors. uBiome has been the recipient of numerous awards, including the Top 10 Most Innovative Companies in Healthcare (Fast Company), Top Prize at the IVY Awards, and CNN 10: Startups To Watch. uBiome founded with crowdfunding campaign for the uBiome IRB uBiome receives Series A funding from Y Combinator and Andreessen Horowitz. uBiome has academic partnerships with leading institutions around the world, including Harvard, Stanford, UCSF, University College London, the National University of Singapore, and the Garvan Institute of Australia. uBiome announces research partnership with the Centers for Disease Control and Prevention (CDC) to study hospital-acquired infections in 10,000 people. uBiome Publishes Peer-Reviewed Scientific Paper in PLOS ONE on First Version of Technology for Gut Health Screening Test. uBiome lab certified by College of American Pathologists, placing it in the top 3% of laboratories worldwide. uBiome closes Series B funding round led by 8VC, supported by other leading investors. uBiome launches SmartGut, world’s first sequencing-based clinical microbiome test, providing patients and doctors with actionable insights to improve gut health. uBiome launches SmartJane, world’s first sequencing-based vaginal microbiome test, providing patients and doctors with actionable insights to improve women’s health. Available to all ages, parental permission needed if under 18. Available to all ages, parental permission needed if under 18. It is recommended that any individual who is – or has been – sexually active or who may have concerns about the risk of cervical cancer, should be regularly screened for HPV. Even if you have been vaccinated, getting screened can help you have more information about your future risk. For more information, see the Are you a licensed healthcare provider? Read about the benefits of SmartJane to discover how SmartJane can help you provide better care for patients. SmartJane does not screen for cancer and is not intended to replace traditional Pap smears or well woman visits. SmartJane is only available with a valid lab test order from a healthcare provider. SmartJane™ is an insurance-reimbursed test ordered by a healthcare provider. We do bill your health insurance, however, during our pilot period, our comprehensive patient assistance programs will cover all costs not covered by your health insurance provider. You may receive an Explanation of Benefits (EOB) from your insurance company. An EOB is NOT a bill. It is simply informational and shows how your insurance processed the claim for your uBiome service. uBiome We are pioneering a new era of microbiome-based precision medicine. uBiome is the leading microbial genomics company. CNN’s close look at 30 innovative companies that are changing the world; uBiome selected in the Futurist Category uBiome Ranked #6 for Most Innovative Companies in the Healthcare Category Business Insider: 30 Under 30 uBiome was founded in 2012 by Stanford-, Oxford-, and UCSF-educated researchers. We are funded by Y Combinator, Andreessen Horowitz, and other leading investors. uBiome has been the recipient of numerous awards, including the Top 10 Most Innovative Companies in Healthcare (Fast Company), Top Prize at the IVY Awards, and CNN 10: Startups To Watch. uBiome founded with crowdfunding campaign for the uBiome IRB uBiome receives Series A funding from Y Combinator and Andreessen Horowitz. uBiome has academic partnerships with leading institutions around the world, including Harvard, Stanford, UCSF, University College London, the National University of Singapore, and the Garvan Institute of Australia. uBiome announces research partnership with the Centers for Disease Control and Prevention (CDC) to study hospital-acquired infections in 10,000 people. uBiome Publishes Peer-Reviewed Scientific Paper in PLOS ONE on First Version of Technology for Gut Health Screening Test. uBiome lab certified by College of American Pathologists, placing it in the top 3% of laboratories worldwide. uBiome closes Series B funding round led by 8VC, supported by other leading investors. uBiome launches SmartGut, world’s first sequencing-based clinical microbiome test, providing patients and doctors with actionable insights to improve gut health. uBiome launches SmartJane, world’s first sequencing-based vaginal microbiome test, providing patients and doctors with actionable insights to improve women’s health. SmartGut™ is the world’s first sequencing-based clinical microbiome test, providing actionable information on dozens of bacteria to help you and your doctor manage gut conditions like Inflammatory Bowel Disease, (IBD), irritable bowel syndrome (IBS) including Ulcerative Colitis and Crohn’s Disease, and even obesity and diabetes. SmartGut is available through healthcare providers. SmartJane™ is the world’s first sequencing-based clinical microbiome test for vaginal health, providing genotyping of high-risk (14 strains) and low-risk HPV (5 strains), four common STIs (chlamydia, gonorrhea, syphilis, and mycoplasma genitalium) and 23 commensal bacteria to better understand your vaginal health. SmartJane is available through healthcare providers. Explorer™ helps consumers explore the universe within. Track your diet and lifestyle and learn how your bacteria can help you boost your wellness and stay fit. With over 50 scientists working on the uBiome team from universities including UCSF, Stanford, Harvard, UCSD, Cambridge (UK) and Oxford (UK), over 300 scientific papers, and over 100 patents filed (73 published, 6 granted) on our technology, uBiome continues to break new ground scientifically.